CaridianBCT, Inc. Launches Mononuclear Cell Collection Protocol

Published: Nov 20, 2008

LAKEWOOD, Colo.--(BUSINESS WIRE)--CaridianBCT, a leading global provider of technology, products and services in therapeutic systems, automated blood collections, whole blood processes and pathogen reduction technologies, announced today that the Spectra Optia® system Mononuclear Cell (MNC) Collection protocol is now available for use in Europe, Australia, Africa and the Middle East.

Back to news